Eaton Vance Management’s AngioDynamics ANGO Stock Holding History

Eaton Vance Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,631	Closed	-$128K	–	1846
2021 Q4	$128K	Sell	4,631 -34	-0.7%	-$938	﹤0.01%	1736
2021 Q3	$0	Sell	4,665 -625	-12%	-$16.7K	﹤0.01%	2016
2021 Q2	$144K	Buy	5,290 +4,724	+835%	+$115K	﹤0.01%	1743
2021 Q1	$13K	Buy	+566	New	+$11.4K	﹤0.01%	2255

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Eaton Vance Management's ANGO Position: Q1 2022 in Review

Eaton Vance Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 4,631 shares — an estimated $128K sold.

Eaton Vance Management first reported a position in ANGO in Q1 2021 and held it in 4 quarters. The position peaked at $144K in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

Eaton Vance Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
Eaton Vance Management sold 4,631 AngioDynamics shares in Q1 2022, an estimated $128K.
Eaton Vance Management first reported a position in AngioDynamics in Q1 2021 and held it in 4 quarters.
Eaton Vance Management's AngioDynamics position peaked at $144K in Q2 2021.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.